DE SB278

Creates the Controlled Substance Advisory Committee to act in an advisory capacity to the Secretary on matters relating to controlled substance regulation.

Establishes requirements that applicants must have an active Federal DEA registration and relevant underlying professional license in Delaware before receiving controlled substance registration; adds professional license discipline in any jurisdiction as grounds for denial or discipline of registration.

Increases the Secretary's authority to fine violators from $500 to $1,000 per violation and revises the process for temporary suspension of registrations to provide 24 hours' notice and allow expedited hearings within 15 days.

Requires dispensers to obtain and review a patient's 12-month utilization report from the Prescription Monitoring Program when the dispenser has reasonable belief a patient may be seeking controlled substances for non-medical reasons.

Clarifies that all hearings under controlled substance regulations are governed by the Administrative Procedures Act and limits grounds for show cause orders to instances where registrants no longer meet registration requirements or fail to complete mandatory continuing education.